Download Pharmacy Shortages – February 27, 2015 (Updated monthly, if not

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Adherence (medicine) wikipedia , lookup

Compounding wikipedia , lookup

Jet injector wikipedia , lookup

Specialty drugs in the United States wikipedia , lookup

Epinephrine autoinjector wikipedia , lookup

Electronic prescribing wikipedia , lookup

Pharmacist wikipedia , lookup

Pharmacy wikipedia , lookup

Transcript
Pharmacy Shortages – February 27, 2015 (Updated monthly, if not more often)
Dear Colleagues,
Below and the following link http://www.aahs.org/medstaff/?page_id=3269 (which has the complete
AAMC Drug Shortage list) are the AAMC Critical Drug Shortages for February 2015. As everyone knows
this is a moving target and changes often. The most critical items are the ones listed below with the
complete list including the ones below see link above. Please forward to your colleagues since many may
not see or receive this e-mail. If anyone wishes to be added please let me know and I will add to the group.
1. Azithromycin IVPB NS 250mL and D5W 250 mL– Due to shortage of both NS and D5W
and if
azithromycin is truly needed consider oral dosage forms.
250mL Pharmacy is asking providers to limit use of IV Azithromycin
. If continued
use continues this may impact other IV medications that need to be in NS or D5W 250mL
solutions (i.e. amiodarone IV, pressors, antibiotics, etc.). Currently all three manufactures,
Baxter, BBraun, and Hospira have all presentation on allocations. It is unknown at this time
when the companies can provide a release date.
2. Neostigmine injection – Has been on/off backorder for a while reducing stock in pharmacy slowly.
Supply is not consistent but has improved over recent weeks. Pharmacy is using a combination of
vials that ae released plus compounded syringes from Pharmedium. Primarily affect anesthesia and
separate communications have been sent out to anesthesia leadership. Continue to reduce use if
appropriate. May be able to augment neostigmine use with the combination of atropine and
edrophonium (Enlon). Current estimates are ~3 weeks on hand, slowly improving.
3. Norepinephrine pre-made IV solutions – Currently on allocation from Pharmedium due to lack of
D5W 500 mL bags, not due to drug. All pre-made bags are limited to ED first dose orders only
which are still in the Pyxis machines. We have enough pre-made bags on hand to supply only ED
first doses. All other Pyxis machine locations where pre-made bags are located have been
removed. Vial supply is currently stable but increases in reserves have been obtained.
4. Pipercillin/Tazobactam injection (Zosyn) – Out of stock at the wholesaler. Limited ability to obtain
directly from manufacture and from secondary markets. Pharmacy received an allocated amount
each week. With using alternatives (see below) we have been able to stretch the use of Zosyn and
limit use to primarily CCU patients as well as those patients consulted by an Infectious Disease
physician. Alternatives for Zosyn were approved by Infectious Disease, Dr. Clance (Epidemiologist)
and Pharmacy Leadership are included below.
Indication
Antibiotic to change to
Soft tissue (empiric)
Unasyn +/- levofloxacin if needed for pseudomonas coverage
Intra-abdominal
Cefoxitin or Cefepime + metronidazole
HCAP
Cefepime + metronidazole
Sepsis
Cefepime
Neutropenic fever
Cefepime
NICU
Dr. Clance to work with directly
5. Medications out of stock include – ammonium chloride, droperidol vials, epinephrine preservative
free ampules, hydroxyzine injection, indigo carmine injection, methyldopa injection, nitroglycerine
IV vial, pancuronium injection, and phentolamine mesylate injection.
6. New shortage products – ketorolac injection
Please forward to staff and colleagues as needed. If you have further questions about this please do not hesitate to
ask or e-mail me, Jared Calish, PharmD, Pharmacy Clinical Coordinator [email protected].
Pharmacy Shortages – February 27, 2015 (Updated monthly, if not more often)
7. Medications discontinued by manufacture – caffeine benzoate IV, phentolamine, pralidoxime
injection and sodium thiosulfate IV
8. Resolved – calcium gluconate injection, digoxin 250 mcg/mL injection, erythromycin injection,
indocyanine green, lidocaine 3.5% ophthalmic ointment (Atken), and proparacaine 0.5% ophthalmic
solution.
Please forward to staff and colleagues as needed. If you have further questions about this please do not hesitate to
ask or e-mail me, Jared Calish, PharmD, Pharmacy Clinical Coordinator [email protected].
Pharmacy Shortages – February 27, 2015 (Updated monthly, if not more often)
Situation:
To inform all healthcare personnel about imminent or already occurring medication shortages facing AAMC.
Background:
Due to a variety of reasons AAMC is currently faced with the following medication shortages listed below
with alternatives or other information provided as needed or known to the Pharmacy Department.
Assessment:
Medication currently designated as critical shortages for AAMC are listed below:
1. Ammonium chloride vials – Long term back order since March 2011, out of stock.
2. Caffeine benzoate IV vials – Out of stock at the wholesaler, caffeine citrate is available. No
estimate release date is known; only one manufacturer exist – American Regent. No release date
given.
3. Caffeine Citrate Oral Solution – Out of stock of oral solution at wholesaler since mid-December
2014. IV solution no issues obtaining at this time. Primarily used in NICU.
4. Calcium chloride injection – Wholesaler is out of stock of vials but able to supply with pre-filled
syringes. Pharmacy has no vials on hand only syringes.
5. Dexamethasone 4mg/mL 1mL injection vials – Out at wholesaler. Larger size vials available on
limited basis. Obtaining from secondary markets.
6. Droperidol – American Regent sole manufacture and currently not making for various
manufacturing reasons. Pharmacy is out of stock since November 2012.
7. Epinephrine preservative free ampules – Manufacturing delays in producing product causing the
delay plus an increase demand. Pharmacy is out of stock since November 2012.
8. Hydralyzine injection – out at the wholesaler. Only able to receive product directly on allocation
from the manufacture. AAMC has about 7-10 days on hand at present.
9. Hydroxyzine IV – all sizes are not available from wholesaler and Pharmacy is out of stock of this
medication. Pharmacy has a limited supply of single dose 10 mL vials that are drawn up as needed
but this too is dwindling fast.
10. Indigo carmine injection – Currently only one manufactured left supplying the market limiting
supply. Pharmacy has zero vials on hand.
11. Methyldopa IV – Sole manufacture, American Regent had recalled the product in 2011. None
currently available.
12. Morphine PF injection – Out of stock at wholesaler of the 25 and 50mg/mL concentration. Limited
amount left in AAMC. Expected release now changed to 1st quarter 2015.
13. Neostigmine injection – Has been on/off backorder for a while reducing stock in pharmacy slowly.
Supply is not consistent but has improved over recent weeks. Pharmacy is using a combination of
vials that ae released plus compounded syringes from Pharmedium.
14. Nitroglycerine IV Vial – Current none on hand. Limited availability of nitroglycerine bottles but
appear available for time being. Limited to one manufacture which cannot keep up with demands.
15. Norepinephrine pre-made IV solutions – Currently on allocation from Pharmedium due to lack of
D5W 500 mL bags, not due to drug.
16. Oxycodone/acetaminophen 5/325 solution (Roxicet) – Manufactures are validating new source of
raw materials thus causing the delay. Estimated release date mid-April 2015 (updated).
17. Pancuronium IV – Long term backorder with manufacture (6/2012), no estimated release date at
this time.
18. Phentolamine mesylate injection – Out of stock at wholesaler and both manufactures have stopped
making for now. Unknown if they will resume. Pharmacy has ZERO vials on hand. Per
manufacture, this product has been discontinued.
Please forward to staff and colleagues as needed. If you have further questions about this please do not hesitate to
ask or e-mail me, Jared Calish, PharmD, Pharmacy Clinical Coordinator [email protected].
Pharmacy Shortages – February 27, 2015 (Updated monthly, if not more often)
19. Pipercillin/Tazobactam injection (Zosyn) – Out of stock at the wholesaler. Limited ability to obtain
directly from manufacture and from secondary markets. Pharmacy received an allocated amount
each week.
20. Pralidoxime chloride (Protopam) – All stock expired and manufactured have stopped making.
21. Prochlorperazine injection – One manufacture that supplies this medication closed in early 2014.
This leaves one sole manufacture to supply; therefore demand is exceeding production of this
product. Limited stock available due to complications with bar code.
22. Sodium thiosulfate vials – Not available from wholesaler at this time (3/2013). Pharmacy out of
stock.
Recommendations:
1. Ammonium chloride vials – AAMC has very little historical use, primarily used for treatment of
hypochloremia or hypochloremic metabolic alkalosis for patients who cannot receive sodium
chloride and in end-stage renal disease. Consider other standard methods for alkalosis reversal
(bicarbonate drips, dialysis). Out of stock.
2. Caffeine benzoate IV vials – Primarily used to treat emergency respiratory failure associated with
CAN depressant overdoses. It has off-label uses for treatment in the overdose of CNS depressant
agents; although no longer the preferred agent for this indication. Caffeine benzoate was more
commonly used for postdural puncture headache and in combination of ECT to prolong seizure
duration. The Caffeine citrate formulation is use for neonates for apnea.
3. Caffeine Citrate Oral Solution – IV solution available and can be used as an oral solution for the
NICU (primary use).
4. Calcium chloride injection – Zero vials remain in AAMC, but Pharmacy has increased the
compliment of syringes to compensate use.
5. Dexamethasone 4mg/mL 1mL injection vials – Trying to prioritize what stock is left for the OR.
For additional information please the following links:
Table 1 Glucocorticoid Comparison:
http://www.ashp.org/DocLibrary/Policy/DrugShortages/dexamethasone-sodiumphosphatecurrent020112TABLEONE.aspx
Table 2 Alternative to Dexamethasone in Selected Situations:
http://www.ashp.org/DocLibrary/Policy/DrugShortages/dexamethasone-sodiumphosphatecurrent020112TABLETWO.aspx
6. Droperidol – Pharmacy is currently out of stock of this medication. There are other antiemetic
alternatives to consider: ondansetron, metoclopramide, promethazine, and prochlorperazine (IV
limited availability). Most of these medications are available as an injection, oral, and rectal
formulations.
7. Epinephrine preservative free ampules – The preservative free vials primarily used in the operating
room. Regular non-preservative free vials are appropriate to use based on the package insert. An
alternative is the regular epinephrine vials or ampules. These vials contain 0.1% sodium bisulfate
which is compatible for ophthalmic use. No estimation from manufacture on return of product.
8. Hydralyzine injection – AAMC currently has limited amount on hand, approximately 7-10 days.
Alternatives to consider are oral hydralyzine, IV labetalol, and IV enalaprilat
9. Hydroxyzine IV – Currently none on hand. Please consider alternatives such as diphenhydramine
or cetirizine for urticaria/atopic dermatitis/pruritus. No estimated time of release updated to
February 2015.
10. Indigo carmine injection – There is no single dye that can replace indigo carmine. Potential options
include methylene blue and indocyanine green. Choice of alternative agent will depend on type of
procedure and prescriber discretion, as well as product availability. Many of the marker dyes are
on back-order. See “Dye Agent Alternatives” on the drug shortage site for more information.
Please forward to staff and colleagues as needed. If you have further questions about this please do not hesitate to
ask or e-mail me, Jared Calish, PharmD, Pharmacy Clinical Coordinator [email protected].
Pharmacy Shortages – February 27, 2015 (Updated monthly, if not more often)
11. Methyldopa IV – None available at AAMC, consider alternatives: IV hydralyzine or IV labetolol.
12. Morphine PF injection – conserve preservative free morphine as much as needed. May need to
purchase other concentrations to help out usage.
13. Neostigmine injection – Primarily affect anesthesia and separate communications have been sent
out to anesthesia leadership. Continue to reduce use if appropriate. May be able to augment
neostigmine use with the combination of atropine and edrophonium (Enlon). Current estimates
are ~3 weeks on hand, slowly improving.
14. Nitroglycerine IV Vial – Considering use premade nitroglycerine drips. Consider oral, sublingual, or
topical applications when applicable. Pharmacy is drawing syringes for Cath Lab use as needed.
15. Norepinephrine pre-made IV solutions – All pre-made bags are limited to ED first dose orders only
which are still in the Pyxis machines. All other Pyxis machine locations pre-made bags were
removed. AAMC currently has about 70 pre-mixed bags on hand in the Pharmacy. Until next
supply is obtain this may only last about 5-7 days. Vial supply is currently stable but increases in
reserves have been obtained.
16. Oxycodone/acetaminophen 5/325 solution (Roxicet) – if not able to tablets an alternative alert is
currently directing prescriber to acetaminophen/oxycodone individual components as liquids or
hydrocodone elixir. Main Pharmacy is out and Clatanoff Pharmacy has limited amount on hand.
17. Pancuronium IV – None available at AAMC. Alternatives include succinylcholine, cisatracurium,
and/or vecuronium.
18. Phentolamine mesylate injection – An alternative for use for extravasations includes terbutaline as
a 1:9 ratio with saline as the base solution. IV Therapy is aware and this alternative was approved
by P&T in 2012. An alternative alert is active in EPIC directing prescribers to the alternative.
19. Pipercillin/Tazobactam injections (Zosyn) – With using alternatives (see below) we have been able
to stretch the use of Zosyn. Limiting use to primarily CCU patients as well as those patients
consulted by an Infectious Disease physician. Alternatives for Zosyn were approved by Infectious
Disease, Dr. Clance (Epidemiologist) and Pharmacy Leadership are included below.
Indication
Antibiotic to change to
Soft tissue (empiric)
Unasyn +/- levofloxacin if needed for pseudomonas coverage
Intra-abdominal
Cefoxitin or Cefepime + metronidazole
HCAP
Cefepime + metronidazole
Sepsis
Cefepime
Neutropenic fever
Cefepime
NICU
Dr. Clance to work with directly
20. Pralidoxime chloride (Protopam) – None available at AAMC. Use in conjunction to treat
organophosphate insecticide toxicity and cholinesterase inhibitor toxicity. Alternatives include
using Mark-1 auto-injector. AAMC Emergency Management Director has already been notified
21. Prochlorperazine injection – Limited stock available at AAMC (~10 vials). Several alternatives exist
in several formulations (oral, injections, SL, liquid, and rectal). Several alternatives include:
ondansetron, promethazine, and metoclopramide.
22. Sodium thiosulfate vials – Currently found as an individual agent and in combination with our
Cyanide antidote kits. This product is out of stock. Information was forwarded to AAMC
Emergency Preparedness Director and our local strategic stockpile liaison. Alternative antidote:
hydroxocobalamin.
Please forward to staff and colleagues as needed. If you have further questions about this please do not hesitate to
ask or e-mail me, Jared Calish, PharmD, Pharmacy Clinical Coordinator [email protected].